Cg Oncology - CGON - Stock Price & News | The Motley Fool

Real time Cg Oncology (CGON) stock price quote, stock graph, news & analysis.

$33.90
OFF

Cg Oncology Stock Price Today (NASDAQ: CGON) Quote

4 weeks from now

4 days ago · CGON News. CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference. ... (NASDAQ: CGON) Cg Oncology stock price per share is $33.90 …

wallstreetzen.com

$63.88
OFF

CG Oncology (CGON) Stock Forecast And Price Target 2024

4 weeks from now

Nov 22, 2024 · According to the 9 analysts' twelve-month price targets for CG Oncology, the average price target is $63.88. The highest price target for CGON is $75.00, while the lowest …

marketbeat.com

FAQs about Cg Oncology - CGON - Stock Price & News | The Motley Fool Coupon?

How much is CG oncology worth?

The company's lead drug targets a sizable addressa... CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq. ...

Does CG oncology pay a dividend?

CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California. More... CGON does not currently pay a dividend. Pie chart with 6 slices. End of interactive chart. Go Premium to see ratings on CGON peers. ...

Is CG oncology a good IPO?

Biotech stocks have fallen about 1% so far this year. With a lead asset in advanced Phase-III testing, CG Oncology, which debuts Thursday on the NASDAQ, is one of the year's most highly anticipated IPOs. The company's lead drug targets a sizable addressa... ...

What does CG oncology stand for?

IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone blad... ...

Will CG Oncology GO Public?

The firm aims to list on the Nasdaq under the symbol CGON. CG Oncology has filed to go public with an IPO on the NASDAQ. CG Oncology has received fast track designation and breakthrough designation needed to accelerate US FDA submission. ...

Will CG oncology raise $100 million in a public offering?

IRVINE, Calif.-- (BUSINESS WIRE)--CG Oncology Announces Pricing of Upsized Initial Public Offering. CG Oncology, a Phase 3 biotech developing an oncolytic immunotherapy for bladder cancer, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. ...